Brief: Abliva Announces Termination Of License Agreement With Fortify Therapeutics

Abliva AB

12/01/2021 07:32

Jan 12 (Reuters) - Abliva AB  ABLI.ST :
    * ABLIVA ANNOUNCES TERMINATION OF LICENSE AGREEMENT WITH
FORTIFY
THERAPEUTICS
    * AS A CONSEQUENCE OF TERMINATED LICENSING AGREEMENT, ABLIVA
WILL
REGAIN ALL INTELLECTUAL PROPERTY RIGHTS, AND THERE WILL BE NO
OUTSTANDING FINANCIAL OBLIGATIONS FOR ANY OF PARTIES
    * TODAY ANNOUNCED THAT LICENSE AGREEMENT WITH FORTIFY
THERAPEUTICS, A WHOLLY-OWNED SUBSIDIARY OF BRIDGEBIO, REGARDING
A DEVELOPMENT OF A LOCAL TREATMENT FOR LEBER'S HEREDITARY OPTIC
NEUROPATHY, IS TERMINATED.

Source text for Eikon:  ID:nMFN5lkVxH 
Further company coverage:  ABLI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;  +48 587696600;))